Drug recall · October 23, 2024
Atovaquone Oral Suspension recall
Why: Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.
- Lots / codes
Lot # 2310083, Exp. 09/30/2025
- Quantity
- 1,980 bottles
- Company
- Bionpharma Inc., Princeton, NJ
- Distribution
- Nationwide in the U.S.A.
- Initiated
- September 17, 2024 · Voluntary: Firm initiated
- Classified
- October 15, 2024
- Reported
- October 23, 2024
- Ended
- September 16, 2025
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atovaquone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.